07:00 , Sep 21, 2015 |  BC Week In Review  |  Company News

GlobeImmune cancer news

In August, GlobeImmune hired Cantor Fitzgerald & Co. to evaluate strategic options, including a merger or sale of all or part of the company. Earlier this year, Celgene Corp. (NASDAQ:CELG, Summit, N.J.) exercised its option...
07:00 , Jun 16, 2014 |  BC Week In Review  |  Company News

Celsion, Egen deal

Celsion will acquire fellow cancer company Egen in a cash and stock deal worth up to $44.4 million. Egen will receive an upfront payment of $3.4 million in cash and $10.6 million in Celsion stock,...
07:00 , Sep 9, 2013 |  BC Week In Review  |  Financial News

NewLink financial update

NewLink established an at-the-market program to sell up to $60 million of its common stock. Cantor Fitzgerald & Co. is the sales agent. NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa   Business: Cancer   Date announced:...